ÂÜÀòÂÒÂ×

Steven Delmar is a seasoned financial executive with over 20 years of experience in various leadership roles, including Chief Financial Officer positions at Avolynt, Inc., Islet Sciences, Inc., and Microlog Corporation. Currently serving as CFO at Avolynt, a clinical stage drug development company, Delmar has played a key role in developing innovative treatments for conditions such as NASH and type 2 diabetes. Previous experience includes directing business operations at CSC and serving as CFO at Integrity Management Consulting, where responsibilities encompassed management of accounting, information technology, and budgeting for various government agencies. Delmar's extensive background also includes significant contributions to financial strategy and operations in publicly held companies like ACE*COMM, where roles included both consulting and executive leadership. Delmar holds a BS in Accounting from Clemson University.